Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04880967
Other study ID # ICU Feel Better App
Secondary ID
Status Completed
Phase
First received
Last updated
Start date July 4, 2023
Est. completion date October 11, 2023

Study information

Verified date January 2024
Source Charite University, Berlin, Germany
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study examines the feasibility and efficacy of a mobile application (app), which enables critically ill patients to report perceived patient stressors to their caregivers.


Description:

For many critically ill patients, treatment in an intensive care unit (ICU) is very stressful, and for some of the patients it is a traumatic experience. The domains of patient stressors encompass physical stressors, mental health stressors, communication stressors, and environmental stressors. The experience of stressors during ICU is associated with a higher risk of worse outcomes including delirium, delayed recovery, and post-intensive care syndrome (PICS). In the context of inpatient intensive care medicine, health care professionals (HCP) have problems to correctly rate the extent of their patients' stress. In this study, we examine the feasibility and efficacy of a stressor-reporting system based on a mobile application (app), which allows critically ill patients to evaluate by themselves the intensity of their stressors, and thus, to communicate their stress experience to HCPs. In the first assessment phase of this study, outcome data of a cohort of n=20 patients will be collected (cohort A). Participants of cohort A will not use the ICU Feel Better App. In the second phase, outcome data of another n=20 patients (cohort B) will be collected. Participants of cohort B will have the opportunity to use the ICU Feel Better App from the second day after admission to the ICU until the day of discharge from ICU.


Recruitment information / eligibility

Status Completed
Enrollment 46
Est. completion date October 11, 2023
Est. primary completion date October 11, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients treated in an ICU - Duration of treatment =48h - Age: 18 years and older - Male, female, or divers gender Exclusion Criteria: - Poor language skills - Statement in patient letter or living will that excludes participation - Participation in another prospective treatment study with indication delirium - Refusal of participation

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Germany Department of Anesthesiology and Intensive Care Medicine, CVK/CCM, Charité - University Medicine Berlin Berlin

Sponsors (1)

Lead Sponsor Collaborator
Charite University, Berlin, Germany

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Patient reported perceived severity of patient stressors Patient reported perceived severity of patient stressors (Mean score of patient stressor list ). Range: 0-4, higher scores indicate higher stress. At day 2 or 3 of ICU treatment (before first use of the app) (t1), and at the day before or the day of discharge from ICU (t2). Time until discharge from the intensive care unit, an expected average of 10 days
Secondary Mental distress Mental distress is measured by Patient Health Questionnaire 4 [PHQ-4, range: 0-12, higher scores indicate higher distress] Time until discharge from the intensive care unit, an expected average of 10 days
Secondary Acute perceived stress Acute perceived stress is measured by Stress Thermometer (range: 0-10, higher scores indicate higher stress) Time until discharge from the intensive care unit, an expected average of 10 days
Secondary State anxiety State anxiety is measured with the Faces Anxiety Scale [FAS, range: 1-5, higher scores indicate higher anxiety] Time until discharge from the intensive care unit, an expected average of 10 days
Secondary Pain Pain is measured with the Faces Pain Scale (range: 0-10, higher scores indicate higher pain) Time until discharge from the intensive care unit, an expected average of 10 days
Secondary Self-reported cognitive functioning Self-reported cognitive functioning is measured with a list of problems of cognitive functions (range: 0-4, higher scores indicate worse cognitive functioning) Time until discharge from the intensive care unit, an expected average of 10 days
Secondary Incidence of delirium Incidence of delirium is measured by CAM-ICU twice per day until Time until discharge from the intensive care unit, an expected average of 10 days
Secondary Length of stay Length of stay is measured in days. Time until discharge from hospital, an expected average of 20 days
Secondary Length of intensive care unit stay Length of intensive care unit stay is measured in days. Time until discharge from the intensive care unit, an expected average of 10 days
Secondary Duration of mechanical ventilation Duration of mechanical ventilation is measured in hours. Time until discharge from the intensive care unit, an expected average of 10 days
Secondary APACHE II-Score APACHE II score is measured by the Acute Physiology and Chronic Health Evaluation System II. Time until discharge from the intensive care unit, an expected average of 10 days
Secondary Medication Medication is measured by data retrieved from the patient data management system. Time until discharge from the intensive care unit, an expected average of 10 days
Secondary Treatment Treatment is measured by data retrieved from the patient data management system. Time until discharge from the intensive care unit, an expected average of 10 days
Secondary Diagnoses Diagnoses are measured by ICD-10 codes retrieved from the patient data management system. Time until discharge from the intensive care unit, an expected average of 10 days
Secondary Mode of intensive care unit admission Mode of intensive care unit admission is measured by admission data retrieved from the patient data management system. Time until discharge from the intensive care unit, an expected average of 10 days
Secondary Diagnosis of post-intensive care syndrome (PICS) Diagnosis of PICS is measured by an extensive clinical examination. Up to one month
Secondary Log data per patient Process data of app use: Log data per patient measured from start to end of app use Time until discharge from the intensive care unit, an expected average of 10 days
Secondary Stressor intensity- Process data of app use: Stressor intensity measured from start to end of app use Time until discharge from the intensive care unit, an expected average of 10 days
Secondary Support of study personal Number of app use trials with assistance of study personnel. Time until discharge from the intensive care unit, an expected average of 10 days
Secondary Acceptance of app Patient reported acceptance of app use, daily until the end of app use Time until discharge from the intensive care unit, an expected average of 10 days
Secondary Usability of app Patient reported usability of app, daily until the end of app use Time until discharge from the intensive care unit, an expected average of 10 days
Secondary Relevance and understandability of app stressor items Patient reported relevance and understandability of app stressor items until the end of app use Time until discharge from the intensive care unit, an expected average of 10 days
See also
  Status Clinical Trial Phase
Completed NCT04551508 - Delirium Screening 3 Methods Study
Recruiting NCT05891873 - Delirium in the (Neuro)Intensive/Critical Care in the Adult and Paediatric Czech Populations
Recruiting NCT06027788 - CTSN Embolic Protection Trial N/A
Recruiting NCT04792983 - Cognition and the Immunology of Postoperative Outcomes
Recruiting NCT06194474 - Study on Biomarkers of Postoperative Delirium in Elderly Cardiac Surgery Patients
Completed NCT03095417 - Improving the Recovery and Outcome Every Day After the ICU N/A
Completed NCT05395559 - Prevalence and Recognition of Cognitive Impairment in Hospitalized Patients: a Flash Mob Study
Terminated NCT03337282 - Incidence and Characteristics of Postoperative Cognitive Dysfunction in Elderly Quebec Francophone Patients
Not yet recruiting NCT04846023 - Pediatric Delirium Screening in the PICU Via EEG N/A
Not yet recruiting NCT04538469 - Absent Visitors: The Wider Implications of COVID-19 on Non-COVID Cardiothoracic ICU Patients, Relatives and Staff
Not yet recruiting NCT03807388 - ReMindCare App for Patients From First Episode of Psychosis Unit. N/A
Withdrawn NCT02673450 - PER3 Clock Gene Polymorphism, Clock Gene Expression and Delirium in the Intensive Care Unit.
Recruiting NCT03256500 - Transcranial Direct Current Stimulation for the Treatment of Delirium N/A
Completed NCT02890927 - Geriatric-CO-mAnagement for Cardiology Patients in the Hospital N/A
Not yet recruiting NCT02892968 - ED Ultrasonographic Regional Anesthesia to Prevent Incident Delirium in Hip Fracture Patients N/A
Recruiting NCT03165539 - Cerebral Oxygen Desaturation and Post-Operative Delirium in Thoracic Surgical Patients
Completed NCT02518646 - DElirium prediCtIon in the intenSIve Care Unit: Head to Head comparisON of Two Delirium Prediction Models N/A
Completed NCT02554253 - The Impact of Ketamine on Postoperative Cognitive Dysfunction, Delirium, and Renal Dysfunction Phase 2
Recruiting NCT02305589 - The Clinical Changes Before and After Sugammadex in the Patients Undergoing Hip Surgery on the Aspect of Delirium N/A
Completed NCT02628925 - Nu-DESC DK: The Danish Version of the Nursing Delirium Screening Scale N/A